Sartorius Stedim Biotech, a leading international supplier for the biopharmaceutical and biotech industries, has announced the expansion of its standard range of Flexel® products by Flexel® for Magnetic Mixers. 

This product series, which has so far covered a range of capacities from 50L to 1,000L, now offers new volumes of 1,500 L and 2,000 L, as well as proven scalable, ready-to-use mixing technology to enhance process flexibility in biomanufacturing and optimize manufacturing costs. This single-use magnetic mixing system is designed for aseptic mixing in process development and manufacturing applications. It is ideal for biopharmaceutical processes that require powerful mixing torque, such as buffer preparation, media preparation, product resuspension and homogenization applications.

Flexel® for Magnetic Mixers is a non-invasive, mixing unit that uses extensively qualified Sartorius Stedim Biotech Flexel® 3D bag technology, the proven stainless steel Palletank® container and ATMI patented mixing technology. A stainless steel cross mounted on a pulley system enables the single-use bag to be unfolded for easy filling and optimal drainage. Mixing is based on a bottom-mounted magnetically-driven impeller capable of providing hightorque mixing in large liquid volumes. Powder transfer is facilitated by the

4-inch powder addition port that provides for direct connection of a 15 L or a 30 L powder transfer bag suspended from a powder bag holder. The interchangeable magnetic mixer drive unit is mobile, cart-mounted and designed to interface with any of the Palletanks®.

With this product range extension, Sartorius Stedim Biotech is continuing expand its offering and expertise in single-use mixing technologies and to deliver solutions for all unit operations to accommodate a fast-growing biopharmaceutical market.

For further information click here

Sartorius Stedim Biotech

Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, cell cultivation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of .turning science into solutions.

Headquartered in Aubagne, France, Sartorius Stedim Biotech is listed on the Eurolist of

Euronext Paris. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany. The company employs nearly 2,600 people, and in 2010 earned sales revenue of 432.9 million euros.